Designer Babies Are On the Way. We're Not Ready
By Robert Klitzman,
CNN
| 08. 16. 2019
What if parents could pick and choose their children's genetic makeup? Such arrangements are increasingly possible, posing ethical and social dilemmas that more and more people are now facing.
Many surprises come with having a baby, including learning your child's sex and discovering all the traits they inherited as they grow up. But what if parents could pick and choose their children's genetic makeup instead of leaving those traits up to nature? Such arrangements are increasingly possible, posing ethical and social dilemmas that more and more people are now facing.
In November, Dr. He Jiankui announced that twin girls had been born in China from embryos whose genes he had altered using CRISPR gene-editing technology. According to the magazine Science, he hoped to build a baby-designing business.
In March, a World Health Organization committee argued for a moratorium on clinical human genome editing "until its implications have been properly considered." But no system of global guidance exists to implement or enforce such a ban on the practice. In June, a Russian scientist declared that he plans to proceed anyway.
You can imagine what bad actors with eugenic fantasies could do with this technology. But today, many patients, with the best interest of their future children in mind, choose embryos...
Related Articles
By Jenny Lange, BioNews | 12.01.2025
A UK toddler with a rare genetic condition was the first person to receive a new gene therapy that appears to halt disease progression.
Oliver, now three years old, has Hunter syndrome, an inherited genetic disorder that leads to physical...
By Rachel Hall, The Guardian | 11.20.2025
Couples are needlessly going through IVF because male infertility is under-researched, with the NHS too often failing to diagnose treatable causes, leading experts have said.
Poor understanding among GPs and a lack of specialists and NHS testing means male infertility...
By Pam Belluck and Carl Zimmer, The New York Times | 11.19.2025
Gene-editing therapies offer great hope for treating rare diseases, but they face big hurdles: the tremendous time and resources involved in devising a treatment that might only apply to a small number of patients.
A study published on Wednesday...
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...